|
4.7 microCi 225Ac-MTI-201 Clinical Trials
1 actively recruiting trial across 1 location
Also known as: 4.7 microCi 225Actinium-MTI-201
Tampa, Florida1 trial
Targeted Alpha Particle Radiotherapy for Metastatic Uveal Melanoma
H. Lee Moffitt Cancer Center and Research Institute
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.